Published in Biol Psychiatry on October 25, 2006
Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev (2010) 11.25
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Population genomics in a disease targeted primary cell model. Genome Res (2009) 2.20
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (2008) 1.88
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci U S A (2013) 1.31
d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur J Neurosci (2007) 1.29
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl) (2008) 1.28
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav (2010) 1.25
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet (2009) 1.18
Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion. Mol Psychiatry (2012) 1.15
Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. Handb Exp Pharmacol (2012) 1.12
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. Curr Opin Pharmacol (2014) 1.11
The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex. Neurobiol Dis (2011) 1.04
Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice. Learn Mem (2008) 0.98
Glutamate neurocircuitry: theoretical underpinnings in schizophrenia. Front Pharmacol (2012) 0.94
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues Clin Neurosci (2010) 0.94
D-serine as a gliotransmitter and its roles in brain development and disease. Front Cell Neurosci (2013) 0.89
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice. Genes Brain Behav (2009) 0.85
D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain. J Cell Mol Med (2008) 0.82
Gliotransmitter Release from Astrocytes: Functional, Developmental, and Pathological Implications in the Brain. Front Neurosci (2016) 0.81
Working memory deficits in neuronal nitric oxide synthase knockout mice: potential impairments in prefrontal cortex mediated cognitive function. Biochem Biophys Res Commun (2011) 0.81
Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia. Schizophr Res (2014) 0.80
In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders. Neural Plast (2015) 0.79
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment. Adv Pharmacol (2016) 0.79
A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression. Neurosci Res (2010) 0.78
The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population. PLoS One (2013) 0.78
Association study of serine racemase gene with methamphetamine psychosis. Curr Neuropharmacol (2011) 0.76
Clinical and biochemical study of d-serine metabolism among schizophrenia patients. Neuropsychiatr Dis Treat (2017) 0.75
Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice. Schizophr Res (2015) 0.75
Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat Med (2005) 4.31
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci (2005) 3.92
CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol (2008) 2.62
FUS pathology in basophilic inclusion body disease. Acta Neuropathol (2009) 2.52
Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature (2007) 2.47
Prospective 10-year surveillance of human prion diseases in Japan. Brain (2010) 2.41
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34
Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat Neurosci (2003) 2.17
Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology (2007) 2.11
A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med (2004) 2.01
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet (2005) 1.92
Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry (2010) 1.89
Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry (2008) 1.72
Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J Cell Biol (2003) 1.65
Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci (2002) 1.64
Charge screening by internal pH and polyvalent cations as a mechanism for activation, inhibition, and rundown of TRPM7/MIC channels. J Gen Physiol (2005) 1.55
Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem (2003) 1.55
Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies. J Am Chem Soc (2005) 1.48
Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload. Gen Thorac Cardiovasc Surg (2010) 1.46
Cut-offs for screening prolonged QT intervals from Fridericia's formula in children and adolescents. Circ J (2010) 1.38
Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res (2005) 1.33
Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann N Y Acad Sci (2002) 1.31
Synthesis and biological validation of a ubiquitous quorum-sensing molecule. Angew Chem Int Ed Engl (2004) 1.29
Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices. J Med Chem (2004) 1.29
Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet. Toxicol Appl Pharmacol (2010) 1.26
NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology (2006) 1.24
The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J Biol Chem (2002) 1.24
Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet (2008) 1.23
CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes. Toxicol Appl Pharmacol (2009) 1.23
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord (2009) 1.22
Regulation of N-methyl-D-aspartate receptors by calpain in cortical neurons. J Biol Chem (2005) 1.21
Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol Sci (2008) 1.20
The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J Biol Chem (2004) 1.19
Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am J Psychiatry (2007) 1.17
Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci (2011) 1.17
Association between polymorphisms in the promoter region of the sialyltransferase 8B (SIAT8B) gene and schizophrenia. Biol Psychiatry (2005) 1.15
Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr Res (2010) 1.15
Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Biol Blood Marrow Transplant (2007) 1.12
Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet (2005) 1.11
An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer's disease. Acta Neuropathol (2004) 1.11
D-serine regulates cerebellar LTD and motor coordination through the δ2 glutamate receptor. Nat Neurosci (2011) 1.11
Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. Hum Mol Genet (2009) 1.11
D-amino acid oxidase controls motoneuron degeneration through D-serine. Proc Natl Acad Sci U S A (2011) 1.10
Development of immunopharmacotherapy against drugs of abuse. Curr Drug Discov Technol (2004) 1.10
Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis. Am J Med Genet B Neuropsychiatr Genet (2011) 1.08
Gateway binary vectors with the bialaphos resistance gene, bar, as a selection marker for plant transformation. Biosci Biotechnol Biochem (2010) 1.07
Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry (2009) 1.07
Clinical characteristics of patients with gender identity disorder at a Japanese gender identity disorder clinic. Psychiatry Res (2007) 1.07
Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. Schizophr Bull (2010) 1.07
Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. Ann Hematol (2006) 1.07
Association study of polymorphisms in the 5' upstream region of human DISC1 gene with schizophrenia. Neurosci Lett (2004) 1.06
BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes (2005) 1.05
Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. Toxicol Sci (2009) 1.04
Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation (2005) 1.04
OGFOD1, a member of the 2-oxoglutarate and iron dependent dioxygenase family, functions in ischemic signaling. FEBS Lett (2010) 1.04
MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6. Nucleic Acids Res (2011) 1.02
Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan. J Clin Oncol (2008) 1.01
Medial profrontal cortex and anterior cingulate cortex in the generation of alpha activity induced by transcendental meditation: a magnetoencephalographic study. Acta Med Okayama (2006) 1.01
Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain. J Biol Chem (2010) 1.01
Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol (2007) 1.01
Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies. Acta Neuropathol (2005) 1.01
Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett (2003) 1.00
A new strategy for improved nicotine vaccines using conformationally constrained haptens. J Am Chem Soc (2003) 1.00
Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells. Mol Cancer Ther (2002) 1.00
Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells. J Biol Chem (2010) 0.99
Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch Gen Psychiatry (2010) 0.99
Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity. Acta Neuropathol (2010) 0.99
Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death. Neurobiol Aging (2006) 0.99
Detailed analysis of visitors to cancer-related web sites. J Clin Oncol (2008) 0.98
Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. Blood (2006) 0.98
Crystal structures of collagen model peptides with Pro-Hyp-Gly repeating sequence at 1.26 A resolution: implications for proline ring puckering. Biopolymers (2004) 0.98
The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia. Neurosci Lett (2003) 0.98
Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation. Neuroreport (2003) 0.97
Alzheimer's disease with spastic paresis and cotton wool type plaques. J Neurosci Res (2002) 0.97
Sensitive determination of D-amino acids in mammals and the effect of D-amino-acid oxidase activity on their amounts. Biol Pharm Bull (2005) 0.97
Regulation of synaptic vesicle recycling by calcineurin in different vesicle pools. Neurosci Res (2005) 0.96
Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems. Nat Commun (2012) 0.96
Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. J Clin Psychiatry (2008) 0.96
Assessment of human exposure to polychlorinated biphenyls and polybrominated diphenyl ethers in Japan using archived samples from the early 1980s and mid-1990s. Environ Res (2005) 0.96
A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol Psychiatry (2012) 0.96
Psychiatric comorbidity among patients with gender identity disorder. Psychiatry Clin Neurosci (2010) 0.95
TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients. Am J Med Genet A (2012) 0.95
HIV-1 Tat inhibits long-term potentiation and attenuates spatial learning [corrected]. Ann Neurol (2004) 0.94
A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia. Schizophr Res (2008) 0.94
Effects of alpha-tocopherol on an animal model of tauopathies. Free Radic Biol Med (2004) 0.94
Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci Lett (2003) 0.94
High-resolution structures of collagen-like peptides [(Pro-Pro-Gly)4-Xaa-Yaa-Gly-(Pro-Pro-Gly)4]: implications for triple-helix hydration and Hyp(X) puckering. Biopolymers (2009) 0.94
Brown rice and its component, γ-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice. Diabetes (2012) 0.94